Innovent Biologics, Inc. (FRA:6IB)
Germany · Delayed Price · Currency is EUR 10.60
+0.20 (1.92%)
At close: Nov 27, 2025
Innovent Biologics Market Cap
Innovent Biologics has a market cap or net worth of €17.76 billion as of December 2, 2025. Its market cap has increased by 132.85% in one year.
Market Cap
17.76B
Enterprise Value
17.02B
Revenue
1.36B
Ranking
n/a
PE Ratio
131.99
Stock Price
€10.60
Market Cap Chart
Since October 31, 2018, Innovent Biologics's market cap has increased from 2.09B to 17.76B, an increase of 750.53%. That is a compound annual growth rate of 35.24%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 1, 2025 | 18.00B | 141.38% |
| Dec 31, 2024 | 7.46B | -6.93% |
| Dec 29, 2023 | 8.01B | 29.87% |
| Dec 30, 2022 | 6.17B | -22.46% |
| Dec 31, 2021 | 7.96B | -34.45% |
| Dec 31, 2020 | 12.14B | 216.45% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Oct 31, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SAP SE | 242.88B |
| Siemens Aktiengesellschaft | 176.79B |
| Allianz SE | 141.56B |
| Deutsche Telekom AG | 132.19B |
| Siemens Energy AG | 98.23B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 69.85B |
| Rheinmetall AG | 67.93B |
| Deutsche Bank Aktiengesellschaft | 58.37B |